InMed Pharmaceuticals Inc. (INM)
NASDAQ · Healthcare
InMed Pharmaceuticals Inc. Gross Profit 2021–2025
InMed Pharmaceuticals Inc. annual/quarterly gross profit history and growth rate from 2022 to 2025. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- InMed Pharmaceuticals Inc. gross profit for the quarter ending December 31, 2025 was 184194, a 60.04% decrease year-over-year.
- InMed Pharmaceuticals Inc. gross profit for the twelve months ending December 31, 2025 was 1.2 M, a 8.47% increase year-over-year.
- InMed Pharmaceuticals Inc. annual gross profit for 2025 was 1.7 M, a 55.02% increase from 2024.
- InMed Pharmaceuticals Inc. annual gross profit for 2024 was 1.1 M, a 21.53% decrease from 2023.
- InMed Pharmaceuticals Inc. annual gross profit for 2023 was 1.4 M, a 158.13% increase from 2022.
- InMed Pharmaceuticals Inc. annual gross profit for 2022 was 543546.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
InMed Pharmaceuticals Inc. Gross Profit — FAQ
InMed Pharmaceuticals Inc. (INM) gross profit over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
What is InMed Pharmaceuticals Inc.'s gross profit?
InMed Pharmaceuticals Inc. (INM) reported gross profit of $2M for fiscal 2025.
Where can I see INM's gross profit history?
The chart and table above show InMed Pharmaceuticals Inc.'s gross profit by year and by quarter, including the growth rate.